<?xml version='1.0' encoding='utf-8'?>
<document id="24341672"><sentence text="Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia." /><sentence text="Drug-Related Problems (DRPs) commonly occur among type 2 diabetes mellitus (T2DM) patients" /><sentence text=" However, few studies have been performed on T2DM patients with dyslipidemia" /><sentence text=" This purpose of this study was to assess drug-related problems (DRPs) and factors associated with its occurrence" /><sentence text="" /><sentence text="The retrospective study involved 208 T2DM in-patients and out-patients with dyslipidemia, and was conducted at a tertiary hospital in Malaysia from January 2009 to December 2011" /><sentence text=" The identification and assessment of DRPs were based on the Pharmaceutical Care Network Europe (PCNE) tool version 5" /><sentence text="01" /><sentence text=" The potentially inappropriate medication use in older adults was assessed based on the American Geriatrics Society updated Beers Criteria" /><sentence text="" /><sentence text="A total of 406 DRPs were identified" /><sentence text=" Among these patients, 91" /><sentence text="8% had at least one DRP, averaging 1" /><sentence text="94Â±1" /><sentence text="10 problems per patient" /><sentence text=" The majority of T2DM patients with dyslipidemia (91" /><sentence text="8%) had at least one DRP" /><sentence text=" The most frequent types of DRP were potential drug-drug interaction (18" /><sentence text="0%), drug not taken or administered (14" /><sentence text="3%) and insufficient awareness of health and diseases (11" /><sentence text="8%)" /><sentence text=" Anti-hypertensive, lipid-modifying and anti-diabetic agents were the drug classes that were most likely to be associated with DRPs" /><sentence text=" Male gender, renal impairment, polypharmacy and poor lipid control were factors that were significantly associated with DRP in diabetic dyslipidemia patients" /><sentence text="" /><sentence text="Early identification of DRPs and factors associated with them are essential to prevent and resolve DRPs in T2DM patients with dyslipidemia" /><sentence text="" /></document>